Laurie Stelzer

Laurie serves as a board member to Sionna and is Chief Financial Officer of Orna Therapeutics, a biotechnology company focused on RNA therapeutics. She also currently serves on the board of PMV Pharmaceuticals, Inc and Spyre Therapeutics, Inc.  Laurie has over 25 years of finance and business development leadership experience in the biopharmaceutical industry.  She has held leadership roles in finance, treasury, global accounting, business development, project management, and site operations for a range of biopharmaceutical companies including as Chief Financial Officer of Mirati Therapeutics, Inc., Arena Pharmaceuticals, Inc., and Halozyme Therapeutics, Inc. She also held senior management roles at Shire Plc and Amgen, Inc., and previously served on the board of Surface Oncology, Inc. and Longboard Pharmaceuticals. Laurie earned a B.S. in Accounting from Arizona State University and an M.B.A. from University of California, Los Angeles, Anderson School of Management.